Newsletters

Publications

Newsletters

  • June 2015

    We provide top tier clinical trial services custom-tailored to your Therapeutic project needs. A carefully managed participant database, and local strategic partnerships with healthcare specialists, ensure ongoing access to patient populations, avoiding study-start delays or panel size restrictions.

  • May 2015

    We are proud to have partnered with Cognitive Research Corporation to evaluate the sedation-related safety of Flibanserin in premenopausal women. A research study sponsored by Sprout Pharmaceuticals.

  • April 2015

    We now have the ability to play a key role in the evolution of CDISC standards. As a CDISC Gold member Algorithme Phama can further collaborate with global leaders and contribute toward the development and release of new standards.

  • February 2015

    Last October, Altasciences expanded into the United States with the opening of Algorithme Pharma USA, in Fargo, North Dakota. Today, we are pleased to announce that our first studies were initiated and completed in January, just 91 days from the US contract being signed, and despite the holiday hustle.

  • January 2015

    The Algorithme Pharma team provides full bioanalytical support for Large Molecules through all phases of clinical development, including as part of regulated studies.

Pages